SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-19-129276
Filing Date
2019-04-30
Accepted
2019-04-30 16:05:59
Documents
17
Period of Report
2019-06-12
Effectiveness Date
2019-04-30

Document Format Files

Seq Description Document Type Size
1 DEF 14A d731105ddef14a.htm DEF 14A 536306
2 GRAPHIC g7311051computer1.jpg GRAPHIC 1218
3 GRAPHIC g731105g19i13.jpg GRAPHIC 49737
4 GRAPHIC g731105g19o00.jpg GRAPHIC 19669
5 GRAPHIC g731105g23m79.jpg GRAPHIC 6482
6 GRAPHIC g731105g54o40.jpg GRAPHIC 20281
7 GRAPHIC g731105g64b13.jpg GRAPHIC 54705
8 GRAPHIC g731105g64l08.jpg GRAPHIC 47116
9 GRAPHIC g731105g72n39.jpg GRAPHIC 19458
10 GRAPHIC g731105g87h41.jpg GRAPHIC 7126
11 GRAPHIC g731105g99h00.jpg GRAPHIC 4794
12 GRAPHIC g731105l_2.jpg GRAPHIC 1633
13 GRAPHIC g731105leaf_2.jpg GRAPHIC 1419
14 GRAPHIC g731105mob_2.jpg GRAPHIC 1018
15 GRAPHIC g731105number_2.jpg GRAPHIC 3140
16 GRAPHIC g731105r_2.jpg GRAPHIC 1632
17 GRAPHIC g731105x_1.jpg GRAPHIC 860
  Complete submission text file 0001193125-19-129276.txt   870807
Mailing Address P. O. BOX # 110341 RESEARCH TRIANGLE PARK NC 27709
Business Address 79 T.W. ALEXANDER DRIVE 4501 RESEARCH COMMONS, SUITE 100 RESEARCH TRIANGLE PARK NC 27709 919-213-9835
G1 Therapeutics, Inc. (Filer) CIK: 0001560241 (see all company filings)

IRS No.: 263648180 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38096 | Film No.: 19781652
SIC: 2834 Pharmaceutical Preparations